Peptency Academy · Guide
Regulatory status of peptide patches in the US, EU and UK
How are peptide patches classified and regulated in the US, the EU and the UK?
Abstract, first sentences: regulatory science for this emerging product form is immature and explicit guidance is limited.1 J Control Release 2025
Regulatory content shown for: United States and the Americas.
Known, not known, contested
Known
- The same paper identifies more than twenty critical quality attributes for the product form and ranks which of them need bespoke tests. Source sentence
Abstract, final sentences: a prioritisation exercise identifies the most pertinent attributes.
1 J Control Release 2025
Not known
- The same search method found no controlled delivery study of a patch without microneedles carrying GHK-Cu, BPC-157 or semaglutide. Source sentence
Query run on 11 November 2026; no controlled study of a flat patch delivering these peptides in the results.
2 PubMed search for transdermal patch without microneedles, 11 November 2026
Contested
Nothing listed yet.
United States: drug, cosmetic and device lines
US
- US law defines a cosmetic by use on the body for cleansing, beautifying or altering the appearance. Source sentence
articles intended to be rubbed, poured, sprinkled, or sprayed on, introduced into, or otherwise applied to the human body or any part thereof for cleansing, beautifying, promoting attractiveness, or altering the appearance
3 21 USC 321, definitions (drug, cosmetic) - A drug includes an article, other than food, intended to affect the structure or any function of the body. Source sentence
articles (other than food) intended to affect the structure or any function of the body of man or other animals
3 21 USC 321, definitions (drug, cosmetic) - An FDA draft guidance of November 2019 covers pharmaceutical development and quality for transdermal and topical delivery systems, and it notes that microneedles carry considerations it does not address. (reported by FDA, read through a search summary) Source sentence
Draft guidance scope note: some transdermal systems, such as microneedles, have other considerations not addressed.
4 FDA draft guidance, Transdermal and Topical Delivery Systems, Nov 2019 - Aesthetic microneedling devices are Class II devices under 21 CFR 878.4430, cleared by 510(k). That class covers skin needling devices, not a patch that carries a drug. (reported by FDA, read through a search summary) Source sentence
FDA page: microneedling devices for aesthetic use are Class II under 21 CFR 878.4430.
5 FDA, Microneedling devices page
United States: supplement patches
US
- A 2026 editorial argues that patch dietary supplements sold as natural GLP-1 products break US law, because the Dietary Supplement Health and Education Act requires supplements to be swallowed. Source sentence
The Dietary Supplement Health and Education Act specifies dietary supplement products must be swallowed, so all these products are illegal.
6 Ann Pharmacother 2026 - No certificates of analysis were posted for those products, and many carried no FDA disclaimer. Source sentence
No certificates of analysis were posted, many products lacked the Food and Drug Administration disclaimer
6 Ann Pharmacother 2026
How is a peptide patch classified under US law?
articles (other than food) intended to affect the structure or any function of the body of man or other animals3 21 USC 321, definitions (drug, cosmetic)
Published examples with IDs
Analytical only (no biological model)Journal of controlled release : official journal of the Controlled Release Society 2025
Classification, nomenclature and more than twenty critical quality attributes
- Design
- White paper by international stakeholders on regulatory science of microneedle product forms
- Molecule
- Microneedle product forms not established
Analytical only (no biological model)The Annals of pharmacotherapy 2026
Count of patch products, listed ingredients and posted certificates of analysis
- Design
- Review of patch dietary supplement products sold as natural GLP-1 products
- Molecule
- Supplement patch products not established
- n
- 25
Sources
- 1J Control Release 2025 accessed 11 Nov 2026
- 2PubMed search for transdermal patch without microneedles, 11 November 2026 accessed 11 Nov 2026
- 321 USC 321, definitions (drug, cosmetic) accessed 11 Nov 2026
- 4FDA draft guidance, Transdermal and Topical Delivery Systems, Nov 2019 accessed 11 Nov 2026
- 5FDA, Microneedling devices page accessed 11 Nov 2026
- 6Ann Pharmacother 2026 accessed 11 Nov 2026
About this page
Research-use information. This library summarises published literature and regulator records. It is not guidance for use, not medical advice, and not a statement that any material is suitable for use in people or animals.
Reviewed by the Peptency editorial process. Version 1, edited 11 November 2026, 6 sources.
Cite this page: Peptency Academy. Regulatory status of peptide patches in the US, EU and UK. Version 1./us/academy/guides/peptide-patch-regulatory-status-us-eu-uk/